Tat-HA-NR2B9c

Tat-HA-NR2B9c
Please request pricing for this article.
Request Pricing

Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T81037-5mg 5 mg

7 - 10 business days*

-
TGM-T81037-50mg 50 mg

7 - 10 business days*

-
 
Description: Tat-HA-NR2B9, comprising an HIV-1 Tat transduction domain fragment, an influenza... more
Product information "Tat-HA-NR2B9c"
Description: Tat-HA-NR2B9, comprising an HIV-1 Tat transduction domain fragment, an influenza virus hemagglutinin (HA) epitope-tag, and the C-terminal 9 amino acids of NR2B (NR2B9c), has demonstrated efficacy in reducing infarct size and enhancing neurological function following ischemia-induced cerebral injury in rats [1].
Supplier: TargetMol
Supplier-Nr: T81037

Properties

Conjugate: No

Database Information

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Tat-HA-NR2B9c"
Write a review
or to review a product.
Viewed